Edel SE & Co. KGaA (EDL)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 4.660 |
|---|---|
| 52-week range | 4.000 – 5.700 |
| Return, 1 month / 3 months | +0.0% / −4.9% |
| Return, 1 year / 3 years | +14.0% / +35.2% |
| Trend | Below its 200-day average |
| RSI (14) | 53 |
| Volatility (1 year) | 35.5% |
| Worst drawdown (1 year) | -25.5% |
| Average daily value traded | 0.01M EUR |
| Dividend yield | 6.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Edel SE & Co. KGaA is a German media company based in Hamburg that works in music and publishing. Through its music arm it produces, markets and distributes recordings and handles artists and labels, while its book division publishes titles across several genres. Its customers include music listeners, readers, retailers and business partners in the entertainment and media trade, and it serves markets in Germany and abroad.
On this site Edel SE & Co. KGaA appears as a stock on the XETRA Stock Exchange (Germany), code EDL, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Edel SE & Co. KGaA (EDL) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 4.660 on 23 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 398 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.0% and over the last three months it fell 4.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.3% | ||
| From 52-week high | -18.2% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.9% | ||
| 6-month return | -2.5% | ||
| 12-month return, skipping the last month | 14.0% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.5% | ||
| Liquidity | 20 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.4% | ||
| Years with dividends | 5 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.2% |
|---|---|
| 1 month | +0.0% |
| 3 months | −4.9% |
| 6 months | −2.5% |
| 1 year | +14.0% |
| 3 years | +35.2% |
| 5 years | +60.5% |
Signals
| 50-day / 200-day average | 4.599 / 4.818 |
|---|---|
| Golden / death cross (60 days) | Death, 29 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.119 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Mar 2026 | EUR 0.3000 |
| 28 Mar 2025 | EUR 0.3000 |
| 28 Mar 2024 | EUR 0.3000 |
| 31 Mar 2023 | EUR 0.3000 |
| 1 Apr 2022 | EUR 0.2000 |
| 26 Mar 2021 | EUR 0.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.